Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment response and remission in a double-blind, randomized, head-to-head study of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit hyperactivity disorder.
Dittmann RW, Cardo E, Nagy P, Anderson CS, Adeyi B, Caballero B, Hodgkins P, Civil R, Coghill DR. Dittmann RW, et al. Among authors: caballero b. CNS Drugs. 2014 Nov;28(11):1059-69. doi: 10.1007/s40263-014-0188-9. CNS Drugs. 2014. PMID: 25038977 Free PMC article. Clinical Trial.
Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study.
Dittmann RW, Cardo E, Nagy P, Anderson CS, Bloomfield R, Caballero B, Higgins N, Hodgkins P, Lyne A, Civil R, Coghill D. Dittmann RW, et al. Among authors: caballero b. CNS Drugs. 2013 Dec;27(12):1081-92. doi: 10.1007/s40263-013-0104-8. CNS Drugs. 2013. PMID: 23959815 Free PMC article. Clinical Trial.
Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate.
Nagy P, Häge A, Coghill DR, Caballero B, Adeyi B, Anderson CS, Sikirica V, Cardo E. Nagy P, et al. Among authors: caballero b. Eur Child Adolesc Psychiatry. 2016 Feb;25(2):141-9. doi: 10.1007/s00787-015-0718-0. Epub 2015 May 22. Eur Child Adolesc Psychiatry. 2016. PMID: 25999292 Free PMC article. Clinical Trial.
Melatonin Alleviates Liver Mitochondrial Dysfunction in Leptin-Deficient Mice.
de Luxán-Delgado B, Potes Y, Rubio-González A, Solano JJ, Boga JA, Antuña E, Cachán-Vega C, Bermejo-Millo JC, Menéndez-Coto N, García-González C, Pereira GC, Caballero B, Coto-Montes A, Vega-Naredo I. de Luxán-Delgado B, et al. Among authors: caballero b. Int J Mol Sci. 2024 Aug 8;25(16):8677. doi: 10.3390/ijms25168677. Int J Mol Sci. 2024. PMID: 39201365 Free PMC article.
Influence of Feedstock Particle Size on the Certain Determination of Chlorine and Bromine in Pyrolysis Oils from Waste Electrical and Electronic Equipment Plastics.
Perez-Martinez BB, Lopez-Urionabarrenechea A, Serras-Malillos A, Acha E, Caballero BM, Asueta A, Arnaiz S. Perez-Martinez BB, et al. Among authors: caballero bm. ACS Omega. 2024 Jul 16;9(30):32593-32603. doi: 10.1021/acsomega.4c01415. eCollection 2024 Jul 30. ACS Omega. 2024. PMID: 39100313 Free PMC article.
A randomised trial of short- vs long-term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06-24.
González-San Segundo C, López Campos F, Gómez Iturriaga A, Rodríguez A, Olivera J, Duque-Santana V, Sancho G, Henríquez I, Conde AJ, Valero J, Maldonado X, Glaria L, Caballero B, Sanmamed N, Mases J, Boladeras-Inglada AM, Montijano M, Santos M, Álvarez A, Martínez JI, Couñago F. González-San Segundo C, et al. Among authors: caballero b. BJU Int. 2024 Oct;134(4):568-577. doi: 10.1111/bju.16484. Epub 2024 Jul 23. BJU Int. 2024. PMID: 39041411
239 results